MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Multiple system atrophy(MSA): Clinical features"

  • 2019 International Congress

    Baseline analysis of PROSPECT-M-UK: a longitudinal study of PSP, CBS and MSA

    E. Jabbari, J. Woodside, V. Chelban, A. Costantini, N. Holland, N. Leigh, D. Burn, N. Pavese, A. Gerhard, C. Kobylecki, M. Hu, A. Church, J. Rohrer, H. Houlden, J. Rowe, H. Morris (London, United Kingdom)

    Objective: To complete the baseline analysis of clinical data from the PROSPECT-M-UK study and to assess the impact of applying current MDS PSP diagnostic criteria…
  • 2019 International Congress

    Differential Value of Brain Magnetic Resonance Imaging in MSA-C and SCAs

    M. Kim, JK. Mun, JH. Ahn, JS. Kim, J. Youn, JW. Cho (Seoul, Republic of Korea)

    Objective: Diagnostic value of brain magnetic resonance imaging (MRI) in differentiating multiple system atrophy cerebellar (MSA-C) phenotype and spinocerebellar ataxias (SCAs) was assessed according to…
  • 2019 International Congress

    [18F] FDG-PET findings associated with cognitive impairment if multiple system atrophy

    KW. Park, NR. Choi, SY. Jo, SJ. Kim, YJ. Park, SJ. Chung, CS. Lee (Seoul, Republic of Korea)

    Objective: To explore the cortical metabolic pattern associated with cognitive impairment in multiple system atrophy (MSA). Background: Cognitive impairment (CI) has been increasingly recognized in…
  • 2019 International Congress

    Motor and Non-Motor Symptom Burden in Parkinsonian and Cerebellar Phenotypes of Probable MSA

    M R. Rukmani, R. Yadav, P K. Pal, B. Bhaskarapillai, T N. Sathyaprabha (Bangalore, India)

    Objective: We aimed to assess the disease severity, non-motor symptoms and cardiac autonomic dysfunction in MSA phenotypes. Background: Multiple system atrophy (MSA) is an adult-onset,…
  • 2019 International Congress

    Nocturnal stridor in multiple system atrophy: video-polysomnography and clinical features

    H. Ryu, J. Paek, S. You, M. Kim, Y. Kim, J. Kim, K. Kim, S. Lee, S. Chung (Daegu, Republic of Korea)

    Objective: We aim to study video-polysomnography (VPSG) and clinical features in patients with MSA. First, we investigate whether VPSG findings differ depending on the presence…
  • 2018 International Congress

    MSA Preliminary Panamerican Report

    M. Cesarini, E. Gatto, J. Etcheverry, G. Da Prat, N. Gonzalez Rojas, H. Teive, M. Rodriguez, J. Ziliani, M. Miranda, P. Chana, F. Cardoso, A. Cardozo, C. Uribe Roca, I. Amorin, L. Abaroa, c. Cosentino, Y. Nuñez, A. Lescano, E. Dieguez, A. Alleva, I. Litvan, G. Wenning (La Plata, Argentina)

    Objective: To report the results of the PAN American MSA (PANMSA) database Background: Multiple system atrophy (MSA) is a rare neurodegenerative disease and coordinated efforts…
  • 2018 International Congress

    The difference in cerebellar blood flow reduction in multiple system atrophy and Parkinson’s disease

    N. Murakami, W. Sako, S. Haji, Y. Izumi, R. Kaji (Tokushima, Japan)

    Objective: The aim of this study is to determine if cerebral blood flow (CBF) reduction in the cerebellum could be a tool for differential diagnosis…
  • 2018 International Congress

    [18F]FP-CIT and [18F]FDG PET findings in MSA patients with cognitive impairment

    KB. Lee, YJ. Park, C. Lee (Seoul, Republic of Korea)

    Objective: We investigated the brain dopaminergic system and glucose metabolism in multiple system atrophy (MSA) patients with cognitive impairment. Background: Since the first report of…
  • 2018 International Congress

    Usefulness of a simple symptom assessment scale for multiple system atrophy: data from HoRC-MSA Project

    M. Matsushima, K. Sakushima, I. Yabe, Y. Kanatani, Y. Ito, T. Matsuoka, T. Katayama, H. Uesugi, K. Sako, A. Takei, S. Shimohama, N. Sato, S. Kikuchi, H. Sasaki (Sapporo, Japan)

    Objective: To investigate the usefulness of a symptom assessment scale for multiple system atrophy (MSA) in Hokkaido, Japan from the data of the Hokkaido Rare-disease…
  • 2018 International Congress

    Revision of Diagnosis in Early Parkinsonism with Abnormal Dopamine Transporter Imaging: A Case Series from the PPMI Study

    J. Massa, L. Chahine (Pittsburgh, PA, USA)

    Objective: To describe the characteristics of patients initially diagnosed with idiopathic Parkinson’s Disease (PD) and with abnormal dopamine transporter (DAT) imaging who have a change…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 20
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • An atypical and interesting feature of Parkinson´s disease
    • Nilotinib for treating MSA: A preclinical proof of concept study
    • Effect of marijuana on Essential Tremor: A case report
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley